Tytuł pozycji:
Corrigendum to 'The forefront of ovarian cancer therapy: update on PARP inhibitors': [Annals of Oncology 31 (2020) 1148-1159].
-
Tytuł:
-
Corrigendum to 'The forefront of ovarian cancer therapy: update on PARP inhibitors': [Annals of Oncology 31 (2020) 1148-1159].
-
Autorzy:
-
Mirza MR; Department of Oncology, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: .
Coleman RL; Department of Gynecologic Oncology & Reproductive Medicine, University of Texas MD Anderson Cancer Center, Houston, USA.
González-Martín A; Medical Oncology Department, Clínica Universidad de Navarra, Madrid, Spain.
Moore KN; Stephenson Cancer Center at the University of Oklahoma, Oklahoma City, USA.
Colombo N; Division of Medical Gynecologic Oncology, European Institute of Oncology IRCCS, University of Milan-Bicocca, Milan, Italy.
Ray-Coquard I; Centre Léon Bérard, University Claude Bernard Lyon I, Lyon, France.
Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G.Pascale, Napoli, Italy.
-
Źródło:
-
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 Aug; Vol. 32 (8), pp. 1066-1067. Date of Electronic Publication: 2021 Jun 02.
-
Typ publikacji:
-
Published Erratum
-
Język:
-
English
-
Imprint Name(s):
-
Publication: 2020- : London : Elsevier
Original Publication: Dordrecht ; Boston : Kluwer Academic Publishers, c1990-
-
Entry Date(s):
-
Date Created: 20210606 Latest Revision: 20210719
-
Update Code:
-
20240105
-
DOI:
-
10.1016/j.annonc.2021.05.796
-
PMID:
-
34090767
Erratum for: Ann Oncol. 2020 Sep;31(9):1148-1159. (PMID: 32569725)